Ledger.Open graph →
SEC Form D · filed July 17, 2024

Cartesian Therapeutics, Inc

Offering
$130.0M
Sold
$130.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GAITHERSBURG, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Michael C. Singer · Gaithersburg, MDDirectorTimothy C. Barabe · FORT LAUDERDALE, FLDirectorNishan C. De Silva · Gaithersburg, MDDirectorPatrick A. Zenner · Gaithersburg, MDDirectorCarrie S. Cox · Gaithersburg, MDDirectorBlaine Davis · Gaithersburg, MDExecMurat C. Kalayoglu · Gaithersburg, MDDirectorChris A. Jewell · Gaithersburg, MDExecKemal C. Malik · Gaithersburg, MDDirectorCarsten Brunn · WATERTOWN, MAExec · DirectorMetin A. Kurtoglu · Gaithersburg, MDExecTimothy A. Springer · Waltham, MADirectorEmily A. English · Gaithersburg, MDExecMilos A. Miljkovic · Gaithersburg, MDExecChris A. Jewell · Gaithersburg, MDExecMichael C. Singer · Gaithersburg, MDDirectorKemal C. Malik · Gaithersburg, MDDirectorCarsten Brunn · Watertown, MAExec · DirectorMetin A. Kurtoglu · Gaithersburg, MDExecTimothy C. Barabe · FORT LAUDERDALE, FLDirectorTimothy A. Springer · Waltham, MADirectorNishan C. De Silva · Gaithersburg, MDDirectorPatrick A. Zenner · Gaithersburg, MDDirectorEmily A. English · Gaithersburg, MDExecCarrie S. Cox · Gaithersburg, MDDirectorBlaine Davis · Gaithersburg, MDExecMurat C. Kalayoglu · Gaithersburg, MDDirectorMilos A. Miljkovic · Gaithersburg, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗